| LM_ID | Common Name | Systematic Name | Species Shorthand | Formula | Mass |
|---|---|---|---|---|---|
| LMPR0103010000 | Farnesane skeleton | - | - | - | - |
| LMPR0103010001 | 2E,6E-farnesol (W) | 2E,6E-farnesol | - | C15H26O | 222.1984 |
| LMPR0103010002 | Farnesyl diphosphate (W) | Farnesyl pyrophosphate | - | C15H28O7P2 | 382.1310 |
| LMPR0103010003 | Nerolidyl diphosphate | Nerolidyl pyrophosphate | - | C15H28O7P2 | 382.1310 |
| LMPR0103010004 | Juvenile hormone III (W) | - | - | C16H26O3 | 266.1882 |
| LMPR0103010005 | Nerolidol (W) | - | - | C15H26O | 222.1984 |
| LMPR0103010006 | 2E,6Z-farnesol | 3,7,11-trimethyldodeca-2E,6Z,10-trien- 1-ol | - | C15H26O | 222.1984 |
| LMPR0103010007 | 2E,6Z-farnesal | 3,7,11-trimethyldodeca-2Z,6E,10-trienal | - | C15H24O | 220.1827 |
| LMPR0103010008 | (2-cis,6-cis)-farnesol | (2Z,6Z)-3,7,11-trimethyldodeca-2,6,10- trien-1-ol | - | C15H26O | 222.1984 |
| LMPR0103010009 | 2-cis,6-cis-farnesyl diphosphate | (2Z,6Z)-3,7,11-trimethyldodeca-2,6,10- trien-1-yl trihydrogen diphosphate | - | C15H28O7P2 | 382.1310 |
| LMPR0103010010 | 2-cis,6-trans-farnesyl diphosphate | (2Z,6E)-3,7,11-trimethyldodeca-2,6,10- trien-1-yl trihydrogen diphosphate | - | C15H28O7P2 | 382.1310 |
| LMPR0103010011 | 2-trans,6-cis-farnesyl diphosphate | (2E,6Z)-3,7,11-trimethyldodeca-2,6,10- trien-1-yl trihydrogen diphosphate | - | C15H28O7P2 | 382.1310 |
| LMPR0103010012 | (2-trans,6-trans)-farnesal | (2E,6E)-3,7,11-trimethyldodeca-2,6,10- trienal | - | C15H24O | 220.1827 |
| LMPR0103010013 | (2-cis,6-trans)-farnesol | 3,7,11-trimethyldodeca-2Z,6E,10-trien- 1-ol | - | C15H26O | 222.1984 |
| LMPR0103010014 | 14:0(5Me[R],9Me[R],13Me) | 5R,9R,13-trimethyl-tetradecanoic acid | - | C17H34O2 | 270.2559 |
| LMPR0103010015 | 18:1(5Z)(9Me,13Me,17Me) | 9,13,17-trimethyl-5Z-octadecenoic acid | - | C21H40O2 | 324.3028 |
| LMPR0103010016 | 20:1(5Z)(11Me,15Me,19Me) | 11,15,19-trimethyl-5Z-eicosenoic acid | - | C23H44O2 | 352.3341 |
| LMPR0103010017 | 22:1(5Z)(13Me,17Me,21Me) | 13,17,21-trimethyl-5Z-docosenoic acid | - | C25H48O2 | 380.3654 |
| LMPR0103010018 | 20:2(5Z,9Z)(11Me,15Me,19Me) | 11,15,19-trimethyl-5Z,9Z-eicosadienoic acid | - | C23H42O2 | 350.3185 |
| LMPR0103010019 | 22:2(5Z,9Z)(13Me,17Me,21Me) | 13,17,21-trimethyl-5Z,9Z-docosadienoic acid | - | C25H46O2 | 378.3498 |
| LMPR0103010020 | 20:3(5Z,9Z,17Z)(11Me,15Me,19Me) | 11,15,19-trimethyl-5Z,9Z,17Z- eicosatrienoic acid | - | C23H40O2 | 348.3028 |
| LMPR0103010021 | 22:3(5Z,9Z,19Z)(13Me,17Me,21Me) | 13,17,21-trimethyl-5Z,9Z,19Z- docosatrienoic acid | - | C25H44O2 | 376.3341 |
| LMPR0103010022 | 24:3(5Z,9Z,17Z)(15Me,19Me,23Me) | 15,19,23-trimethyl-5Z,9Z,17Z- tetracosatrienoic acid | - | C27H48O2 | 404.3654 |
| LMPR0103010023 | farnesyl triphosphate | 3,7,11-trimethyldodeca-2,6,10-trien-1- yl tetrahydrogen triphosphate | - | C15H29O10P3 | 462.0974 |
| LMPR0103010024 | - | 13-bromo-10R,11R-dichloro-7,11- dimethyl-3-methylene-4-oxo-6E,8E,12E- tridecatrienoic acid | - | C16H19BrCl2O3 | 407.9895 |
| LMPR0103010025 | - | 13-bromo-10S,11R-dichloro-7,11- dimethyl-3-methylene-4-oxo-6E,8E,12E- tridecatrienoic acid | - | C16H19BrCl2O3 | 407.9895 |
| LMPR0103010026 | - | 10S,11R-dichloro-7,11-dimethyl-3- methylene-4R-hydroxy-6E,8E,12- tridecatrienoic acid | - | C16H22Cl2O3 | 332.0946 |
| LMPR0103010027 | - | 13-bromo-10R,11R-dichloro-7,11- dimethyl-3-methylene-4R-hydroxy-6E,8E, 12E-tridecatrienoic acid | - | C16H21BrCl2O3 | 410.0051 |
| LMPR0103010028 | Canangalia I | methyl (2E,6R)-6-hydroxy-3-methyl-6-(2- methyl-5-oxotetrahydrofuran-2-yl) hex- 2-enoate | - | C13H20O5 | 256.1311 |
| LMPR0103010029 | Canangalia C | (2E,6E,10R)-10-lactoxy-11-hydroxy-3,7, 11-trimethyldodeca-2,6-dienoic acid methyl ester | - | C17H28O6 | 328.1886 |
| LMPR0103010030 | Canangalia D | (2E,6E,10R)-11-hydroxy-10-succinoxy-3, 7,11-trimethyldodeca-2,6-dienoic acid methyl ester | - | C18H28O7 | 356.1835 |
| LMPR0103010031 | Canangalia E | (2E,6E,10R)-11-(3′,4′-dihydroxy- 2′-methylenebutoxy)-10-hydroxy-3,7, 11-trimethyldodeca -2.6-dienoic acid methyl ester | - | C19H30O7 | 370.1992 |
| LMPR0103010032 | Canangalia F | (2E,6E,10R)-11-(2',4'-dihydroxy-3'- methylenebutoxy)-10-hydroxy-3,7,11- trimethyldodeca-2,6-dienoic acid methyl ester | - | C19H30O7 | 370.1992 |
| LMPR0103010033 | Juvenile hormone III skipped bisepoxide | Methyl (2R,3S,10R)-2,3:10,11- Bisepoxyfarnesoate | - | C16H26O4 | 282.1831 |
| LMPR0103010034 | Crannenol A | - | - | C19H28O4 | 320.1988 |
| LMPR0103010035 | Crannenol B | - | - | C17H26O2 | 262.1933 |
| LMPR0103010036 | Crannenol C | - | - | C17H26O3 | 278.1882 |
| LMPR0103010037 | Crannenol D | - | - | C17H26O3 | 278.1882 |